Union Health Minister reviews availability of COVID essential drugs, buffer stocks
The strategic buffer stock has been created for 8 drugs, all of these are available in the country.
New Delhi: Union Minister for Health and Family Welfare and Chemicals and Fertilisers, Mansukh Mandaviya reviewed the supply and availability of COVID-19 related essential medicines in the country.
During the review, it was noted that sufficient stocks of all the essential medicines are available. Raw materials for these drugs are also available in enough quantities.
The strategic buffer stock has been created for 8 drugs, all of these are available in the country. Here is the list of 8 drugs:
1. Tocilizumab
2. Methyl Predinisolone
3. Enaxopirin
4. Dexamethasone
5. Remdesivir
6. Amphotericin B Deoxycholate
7. Posaconazole
8. Intravenous Immunoglobilin (IVIG)
Senior Officials of the Ministry of Health and Family Welfare were present in the review meeting.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.